Woodline Partners’s CytomX Therapeutics CTMX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$5.3M Buy
2,336,899
+679,593
+41% +$1.54M 0.03% 544
2025
Q1
$1.05M Buy
+1,657,306
New +$1.05M 0.01% 763
2024
Q4
Sell
-393,832
Closed -$465K 947
2024
Q3
$465K Buy
+393,832
New +$465K ﹤0.01% 540